Publications dans lesquelles il/elle collabore avec Fernando de Álvaro Moreno (21)

2021

  1. Optimizing the timing of nephrology referral for patients with diabetic kidney disease

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. The concept and the epidemiology of diabetic nephropathy have changed in recent years

    Journal of Clinical Medicine, Vol. 4, Núm. 6, pp. 1207-1216

2013

  1. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503

  2. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease

    BMC Nephrology, Vol. 14, Núm. 1

2012

  1. A propósito de las discrepancias entre documentos de consenso, guías de práctica clínica y normativa legal en el tratamiento de la diabetes tipo 2

    Nefrologia

  2. About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes

    Nefrologia

  3. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients

    Nefrologia

2011

  1. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: The MERENA observational cohort study

    BMC Nephrology, Vol. 12, Núm. 1

2010

  1. 10 razones para el tratamiento con olmesartán/amlodipino en el paciente hipertenso no controlado en nefrología

    International Marketing & Communication

2009

  1. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease

    Renal Failure, Vol. 31, Núm. 10, pp. 869-875

2007

  1. Glomerulopatías secundarias y enfermedades renales asociadas a enfermedades metabólicas. Diabetes mellitus.

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 80, pp. 5157-5163

2005

  1. Directrices y guías de consenso para el manejo de la nefropatía diabética: ¿Son realmente válidas?

    Nefrologia, Vol. 25, Núm. SUPPL.4, pp. 28-33

  2. Epidemiology of diabetic nephropathy in Spain

    Kidney International

  3. Trascendencia de la determinación precoz de microalbuminuria en el riesgo vascular global y nefropatía diabética

    Nefrologia, Vol. 25, Núm. SUPPL.4, pp. 34-41

2004

  1. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study)

    Journal of Nephrology, Vol. 17, Núm. 4, pp. 544-551

  2. Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA study)

    Nephrology Dialysis Transplantation, Vol. 19, Núm. 9, pp. 2347-2353